Inspire Medical Systems Inc (NYSE:INSP) is set to release its Q4 2024 earnings on Feb 10, 2025. The consensus estimate for Q4 2024 revenue is $0.24 billion, and the earnings are expected to come in at ...

Janney Montgomery Scott LLC grew its position in Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 248.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,806 shares of the ...

The market expects Inspire Medical Systems (INSP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

Beyond analysts' top -and-bottom-line estimates for Inspire (INSP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Learn more about whether Inspire Medical Systems, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Inspire Medical Systems (INSP – Research Report), with a ...

MINNEAPOLIS, Minn, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company ...

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA ...

Chairman and Chief Executive Officer of Inspire Medical Systems. “We are also excited to announce the first implants of the new Inspire V neurostimulation system, and a new organizational ...

8 analysts have expressed a variety of opinions on Inspire Medical Systems (NYSE:INSP) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes ...